Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by ganja50on Jul 22, 2015 5:53pm
182 Views
Post# 23950568

RE:Let's cut the nonsense

RE:Let's cut the nonsense"Rather, today's NR if indeed it is new material can possibly be viewed as helpful in convincing HC to allow TLT to hold clinical trials when the real testing will begin. The market knows all this and so should retail investors."

Not true 1320.  You talk about "the market" having established a realistic price, but what is the market in regard to TLT?  It's the .00001% of investors that have actually looked into it.  The circle of knowledgeable investors who have heard of TLT or are able to buy it is beginning to expand and will continue to expand for a couple of years.  And the expansion won't be arithemetic; it will be exponential.

It's really hard for me to understand what you are doing here.  The only thing I can come up with is that you represent potential longs who have not yet filled out their position.

By the way, are you personally short TLT or do you work for a person or group that is short?

I have the silly notion that if you lie answering that question, and you are employed by an investment entity, your group is potentially subject to a law suit, 
True?




Bullboard Posts